www.bmj.com/content/387/... Whilst Chris Hoy’s #prostatecancer diagnosis and prognosis is very sad, experts advise that screening programmes need to be backed up by evidence for the biggest benefit:risk in the population.

#TRANSFORM, funded by @prostatecanceruk.bsky.social & @nihr.bsky.social will provide key evidence to the National Screening Committee needed for #ProstateCancer screening: recruitment begins in 2025!

"Experts agree that current data does not support screening at any age in any group. A political decision to over-ride such expertise is, by definition, not a correct one," says @londonprostate1.bsky.social, Chief Investigator of #TRANSFORM.

In this week's @bmj.com, @mgtmccartney.bsky.social highlights the critical issues with the PSA test for #ProstateCancer screening. The #TRANSFORM trial starts next year and will test new screening pathways. Read the full article here: https://buff.ly/4g1Pmn0

It was a record meeting for Imperial Prostate at #BAUSOncology 2024 with presentations on prostate cancer screening, early detection, molecular imaging and discussion of many of our ongoing/upcoming trials from our fellows, lecturers, and consultants #ATLAS #AVIDITY #FLUORESCE #PACIFIC #TRANSFORM

The protocol paper for the IP8-FLUORESCE trial is now published #openaccess in @bjuijournal.bsky.social ! Excellent work led by Nikhil Mayor and Matt Winkler Keep tuned for the results! Read for free: https://buff.ly/48ZquK5